Stay updated on Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial
Sign up to get notified when there's something new on the Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial page.

Latest updates to the Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial page
- Check3 days agoChange DetectedA new consolidated Locations section has been added with state listings (California, New York, Oregon, Pennsylvania, Utah, Wisconsin) and the previous separate state location headings have been removed. This improves visibility of where the study is conducted.SummaryDifference0.7%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2. This is a minor maintenance update that does not change the study details.SummaryDifference0.1%

- Check39 days agoChange DetectedThe government funding/operating status notice banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check53 days agoChange DetectedNo additions or deletions detected on the page; the study details and layout appear unchanged.SummaryDifference0.4%

- Check82 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference3%

- Check89 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial page.